|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-7-1
|
|
pubmed:abstractText |
The Heart and Estrogen/progestin Replacement Study (HERS) found no overall reduction in risk of coronary heart disease (CHD) events among postmenopausal women with CHD. However, in the hormone group, findings did suggest a higher risk of CHD events during the first year, and a decreased risk during years 3 to 5.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
pubmed-author:BittnerVeraV,
pubmed-author:BlumenthalRogerR,
pubmed-author:DavidsonMichaelM,
pubmed-author:GradyDeborahD,
pubmed-author:HERS Research Group,
pubmed-author:HerdAlanA,
pubmed-author:HerringtonDavidD,
pubmed-author:HlatkyMarkM,
pubmed-author:HsiaJudithJ,
pubmed-author:HulleyStephenS,
pubmed-author:KhanStevenS,
pubmed-author:NewbyL KristinLK,
pubmed-author:VittinghoffEricE,
pubmed-author:WatersDavidD,
pubmed-author:WengerNanetteN
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
288
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-57
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12090862-Aged,
pubmed-meshheading:12090862-Aspirin,
pubmed-meshheading:12090862-Coronary Disease,
pubmed-meshheading:12090862-Estrogen Replacement Therapy,
pubmed-meshheading:12090862-Estrogens, Conjugated (USP),
pubmed-meshheading:12090862-Female,
pubmed-meshheading:12090862-Follow-Up Studies,
pubmed-meshheading:12090862-Humans,
pubmed-meshheading:12090862-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:12090862-Medroxyprogesterone Acetate,
pubmed-meshheading:12090862-Myocardial Infarction,
pubmed-meshheading:12090862-Postmenopause,
pubmed-meshheading:12090862-Risk Factors,
pubmed-meshheading:12090862-Survival Analysis,
pubmed-meshheading:12090862-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
|
|
pubmed:affiliation |
Department of Epidemiology and Biostatistics, University of California, San Francisco, 74 New Montgomery St, Suite 600, San Francisco, CA 94105, USA. dgrady@itsa.ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
